SCHEMBL20769869

SCHEMBL20769869

CCO[Si]1(OC(C)=O)CCCC1

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
LMNA P02545 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20769887 0.96 ALDH1A1 (0.37) ALDH1A1LMNAHSD17B10TSHR
SCHEMBL8854366 0.84 ALDH1A1 (0.33) ALDH1A1HSD17B10TSHR
SCHEMBL22632354 0.81 HSD17B10 (0.32) ALDH1A1HSD17B10TSHR
SCHEMBL9181709 0.79 ALDH1A1 (0.33) ALDH1A1HSD17B10TSHR
SCHEMBL15157466 0.78
SCHEMBL20769862 0.77 ALDH1A1 (0.35) ALDH1A1
SCHEMBL20769888 0.76 ALDH1A1 (0.33) ALDH1A1
SCHEMBL6053267 0.73
SCHEMBL20769858 0.73 ALDH1A1 (0.35) ALDH1A1
SCHEMBL20942802 0.71 ALDH1A1 (0.33) ALDH1A1LMNAHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240182499-A1 ALKOXYSILACYCLIC OR ACYLOXYSILACYCLIC COMPOUNDS AND METHODS FOR DEPOSITING FILMS USING SAME VERSUM MAT US LLC (US) 2024-06-06 US claimed
US-11884689-B2 Alkoxysilacyclic or acyloxysilacyclic compounds and methods for depositing films using same VERSUM MATERIALS US, LLC 2024-01-30 US claimed
US-20220044928-A1 SILICON COMPOUNDS AND METHODS FOR DEPOSITING FILMS USING SAME VERSUM MATERIALS US, LLC (US) 2022-02-10 US claimed
US-11158498-B2 Silicon compounds and methods for depositing films using same VERSUM MATERIALS US, LLC (US) 2021-10-26 US claimed
US-20200354386-A1 ALKOXYSILACYCLIC OR ACYLOXYSILACYCLIC COMPOUNDS AND METHODS FOR DEPOSITING FILMS USING SAME VERSUM MATERIALS US, LLC 2020-11-12 US claimed
EP-3676417-A1 ALKOXYSILACYCLIC OR ACYLOXYSILACYCLIC COMPOUNDS AND METHODS FOR DEPOSITING FILMS USING SAME Versum Materials US, LLC (US) 2020-07-08 EP claimed
CN-111051568-A Alkoxy silicon heterocyclic or acyloxy silicon heterocyclic compound and method for depositing film using the same 弗萨姆材料美国有限责任公司 2020-04-21 CN claimed
WO-2019046449-A1 ALKOXYSILACYCLIC OR ACYLOXYSILACYCLIC COMPOUNDS AND METHODS FOR DEPOSITING FILMS USING SAME VERSUM MATERIALS US, LLC (US) 2019-03-07 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11158498-B2 Silicon compounds and methods for depositing films using same TET2, SMS, TET1 ALDH1A1 1111/4885LMNA 1297/4885HSD17B10 2491/4885
US-11884689-B2 Alkoxysilacyclic or acyloxysilacyclic compounds and methods for depositing films using same KCNC1, KCNH2, PORCN ALDH1A1 3870/4885LMNA 413/4885HSD17B10 1308/4885
US-20240182499-A1 ALKOXYSILACYCLIC OR ACYLOXYSILACYCLIC COMPOUNDS AND METHODS FOR DEPOSITING FILMS USING SAME KCNC1, KCNH2, PORCN ALDH1A1 3870/4885LMNA 413/4885HSD17B10 1308/4885
US-20220044928-A1 SILICON COMPOUNDS AND METHODS FOR DEPOSITING FILMS USING SAME TET2, SMS, TET1 ALDH1A1 1111/4885LMNA 1297/4885HSD17B10 2491/4885
US-20200354386-A1 ALKOXYSILACYCLIC OR ACYLOXYSILACYCLIC COMPOUNDS AND METHODS FOR DEPOSITING FILMS USING SAME KCNC1, KCNH2, PORCN ALDH1A1 3870/4885LMNA 413/4885HSD17B10 1308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.